Wrap Text
Dealing in Securities by an Associate of a Director
Shoprite Holdings Limited
(Incorporated in the Republic of South Africa)
Registration Number: 1936/007721/06
ISIN: ZAE000012084
JSE share code: SHP
A2X share code: SHP
NSX share code: SRH
LUSE share code: SHOPRITE
("Shoprite Holdings")
DEALING IN SECURITIES BY AN ASSOCIATE OF A DIRECTOR
Shareholders are referred to the announcement released on SENS on 11 October 2024 relating to a scrip
borrowing arrangement in terms of which Titan Fincap Solutions (RF) (Pty) Ltd ("Titan Fincap") borrowed
3,831,164 Shoprite Holdings ordinary shares (the "Second Scrip Loan") on 7 October 2024 (the "Second Scrip
Loan Announcement"), and to the announcement released on SENS on 18 October 2023 ("Initial
Announcement").
Titan Fincap has subsequently acquired Shoprite Holdings ordinary shares to settle the Second Scrip Loan,
details of which are set out in the table below.
Shareholders are further advised that the intergroup options between associates of Dr CH Wiese, Titan
Premier Investments (Pty) Ltd ("TPI"), Thibault Square Financial Services (Pty) Ltd ("Thibault"), and Titan
Fincap, as described in the Initial Announcement, remain in place.
In terms of paragraphs 3.63 to 3.74 of the Listings Requirements of the JSE Limited, the following information
is disclosed:
Name of director: Dr CH Wiese
Designation: Non-executive Director
Associate: Titan Fincap
Date of transaction: 1 October 2025
Class of securities: Ordinary shares
Nature of transaction: On-market purchase of ordinary shares and settlement of
Second Scrip Loan by Titan Fincap
Number of securities: 3,831,164
Price per security: R274.01
Total value: R1,049,777,247.64
Nature of interest for director: Indirect beneficial through Titan Fincap controlled by TPI,
of which Dr CH Wiese is a director
Nature of interest for associate: Direct beneficial
Clearance to deal obtained: Yes
In addition, Titan Fincap sold a total return swap, with a reference price of R 274.01 per Shoprite Holdings
ordinary share, which will be settled in cash.
Name of director: Dr CH Wiese
Designation: Non-executive Director
Associate: Titan Fincap
Date of transaction: 1 October 2025
Termination date: 2 October 2025
Class of securities: Ordinary shares
Nature of transaction: Total return swap (off-market)
Number of securities: 3,831,164
Deemed price per security: R274.01 (based on the acquisition price of Shoprite
Holdings ordinary shares)
Total value of the transaction: R1,049,777,247.64
Nature of interest for director: Indirect beneficial through Titan Fincap controlled by TPI,
of which Dr CH Wiese is a director
Nature of interest for associate: Direct beneficial
Clearance to deal obtained: Yes
The above transactions, prior to the exercise of the intra-group options (as outlined in the Initial
Announcement), do not affect any of the voting rights in respect of Shoprite Holdings ordinary shares and
deferred shares held by Thibault.
Cape Town
3 October 2025
Sponsor
Nedbank Corporate and Investment Banking, a division of Nedbank Limited
Date: 03-10-2025 03:30:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.
Sharenet Sites 
